Clinical trial
A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney…
NCT00402168 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00402168 |
|---|---|
| Title | A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids |
| Official title | Belatacept Conversion Trial in Renal Transplantation |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplant |
| Intervention type | Drug |
| Interventions | Belatacept, Cyclosporine A, Tacrolimus |
| Enrollment | 173 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2013 |
| First posted | Nov 22, 2006 |
| Last update posted | Jan 5, 2017 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, France, Germany, India, Mexico, Poland, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: